Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 242 results for "panacea biotec"

Panacea Biotec Limited

on Wednesday said the US Food and Drug Administration has approved the companys abbreviated new drug application for rizatritan benzoate orally disintegrating tablets of 5 mg and 10 mg strengths, which is the generic equivalent of Maxalt-MLT marketed by Merck ... Business Line, 1 day ago
[x]  

9 images for panacea biotec

Investing.com, 1 day ago
Pharmaceutical Tech.com, 2 weeks ago
India Infoline, 3 weeks ago
Moneycontrol.com, 1 month ago
India Infoline, 1 month ago
India Infoline, 1 month ago
Business Standard India, 3 months ago
Financial Express, 3 months ago
Financial Express, 6 months ago
India Infoline

Panacea Biotech soars 18% on USFDA approval

Panacea Biotec Ltd ended at Rs 148.6, up by Rs 22.35 or 17.7% from its previous closing of Rs 126.25 on the BSE after it received approval from the US drug regulator for its migraine tablet. The US FDA has granted the approval for the company's ...
 India Infoline1 day ago Panacea Biotec trades jubilantly on getting USFDA's approval for Rizatriptan Benzoate Tablet  Finalaya.com1 day ago Panacea Biotec gets USFDA's approval for Rizatriptan Benzoate Tablet  Finalaya.com1 day ago Panacea Biotec jumps on report USFDA approves migraine drug  Business Standard1 day ago
[x]  

Panacea Biotec zooms nearly 18% on USFDA nod for migraine drug

Shares of Panacea Biotec today surged nearly 18 per cent after the company inked a pact with UNICEF for supply of Pentavalent Vaccine (Easyfive-TT) in the current year and got approval from the US health regulator for migraine drug. The stock zoomed 17.70 per ...
 Business Standard1 day ago Panacea Biotec inks pact with UNICEF for supply of Pentavalent Vaccine  Finalaya.com1 day ago Panacea inks pact with UNICEF,gets USFDA nod for migraine drug  Money Control1 day ago Panacea inks pact with UNICEF  Express Pharma14 hours ago
[x]  

Panacea Biotec zooms 18% on USFDA approval for migraine drug

Panacea Biotec has zoomed 18% to Rs 149, also its 52-week high on the National Stock Exchange (NSE) in noon deal after the pharmaceutical company announced that it has receive the US regulator's approval for making a migraine drug. The US Food and ...
 Smart Investor1 day ago
Investing.com

BRIEF-Panacea Biotec gets ANDA approval to market generic version of rizatriptan benzoate tablet

n"Jan 18 Panacea Biotec Ltd * Panacea Biotec Ltd says ANDA approval for us market and lta & award from un agencies for supply of pentavalent vaccine (easyfive-TT) * Panacea Biotec Ltd says plans to launch product within Q1 2017 via distribution ...
 Reuters UK1 day ago Panacea Biotec to market generic version of Rizatriptan Benzoate tablets  Money Control1 day ago Panacea Biotec gets ANDA approval for migraine drug  Religare Securities1 day ago

Vaccine Contract Manufacturing Market, 2016 - 2026: Extensive Study of the Current Market Landscape of CMOs Focused on Vaccines

Dublin, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the report to their offering. The "Vaccine Contract Manufacturing Market, 2016 - 2026" report provides an extensive study of the current market landscape ...
 Benzinga.com1 day ago

Hindustan Zinc, Tata Steel, SAIL, NMDC among top 50 companies that hit fresh 52-week highs

NEW DELHI: The benchmark NSE Nifty index reclaimed the psychological level of 8,400 on Wednesday on account of buying in metal as well as selected heavyweight stocks. Over 50 stocks on the NSE hit their fresh 52-week highs in today's trade. The ...
 Economic Times1 day ago
Finalaya.com

Benchmarks pare gains but trade continues in green

SENSEX 27226.11 9.55 0.04% NIFTY 8410.65 12.65 0.15% Indian equities pared most of their initial gains but continue to trade in green in the afternoon session, taking cues from Asian counterparts. Sentiments got some support ...
 Finalaya.com1 day ago

Acute Asthma Global Clinical Trials Review, H2, 2016 by type, region, trend

Publisher's clinical trial report, Acute Asthma Global Clinical Trials Review, H2, 2016″ provides an overview of Acute Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Asthma. Report ...
 Before It's News1 week ago Global Poliomyelitis Clinical Trials Review, H1, 2016 by type, trend, region, Forecasts  Before It's News3 weeks ago Diphtheria Market Clinical Trials Review, H2, 2016 by type, trend, region, Forecasts  Before It's News2 weeks ago Tetanus Market Clinical Trials Review, H2, 2016 by type, region, trend  Before It's News2 weeks ago

Paediatric Vaccine Market: Pneumococcal Indication Segment Anticipated to Be the Most Attractive Segment Through 2026: Global Industry Analysis and Opportunity Assessment, 2016-2026

Global Paediatric Vaccine Market: Towards a better and safer tomorrow Paediatric vaccines are administered to a child in its paediatric age which is from 0 18 years of age. Vaccines are generally given in order to prevent children from diseases ...
 Minyanville1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less